Nature and nurture in neuropsychiatric genetics: Where do we stand?;Lo innato y lo adquirido en la genética neuropsiquiátrica: ¿Dónde estamos?

Dialogues in Clinical Neuroscience

Volumn 12, Issue 1, 2010, Pages 6-22

  Dick, Danielle M ^a,b   Riley, Brien ^a   Kendler, Kenneth S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Alcohol dependence; Gene environment interaction; Genetics; Schizophrenia; Twin study

Indexed keywords

ADOLESCENCE; ADULTHOOD; ALCOHOLISM; ALLELE; ARTICLE; AUTISM; BIPOLAR DISORDER; CHROMOSOME 1Q; CHROMOSOME 22Q; CHROMOSOME PAIRING; CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; DRUG DEPENDENCE; ENVIRONMENTAL FACTOR; GENE DELETION; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC RISK; HEREDITY; HERITABILITY; HETEROZYGOSITY; HUMAN; MEDICAL GENETICS; MENTAL DISEASE; MOLECULAR GENETICS; NEUROPSYCHIATRY; PHENOTYPE; PHENOTYPIC VARIATION; PROMOTER REGION; SCHIZOPHRENIA; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SUBSTANCE ABUSE;

EID: 78649483815     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (185)

1. Kendler KS, Baker JH. Genetic influences on measures of the environment: a systematic review. Psychol Med. 2007;37:615-626.
2. Harden KP, Hill JE, Turkheimer E, Emery RE. Gene-environment correlation and interaction in peer effects on adolescent alcohol and tobacco use. Behav Genet. 2008;38:339-347.
3. Hill J, Emery RE, Harden KP, Mendle J, Turkheimer E. Alcohol use in adolescent twins and affiliation with substance using peers. J Abnorm Child Psychol. 2008;36:81-94.
4. Dick DM, Pagan JL, Holliday C, et al. Gender differences in friends' influences on adolescent drinking: a genetic epidemiological study. Alcoholism: Clin Exp Res. 2007;31: 2012-2019.
5. Kendler KS, Jacobson KC, Gardner CO, Gillespie N, Aggen SA, Prescott CA. Creating a social world: a developmental twin study of peer-group deviance. Arch Gen Psychiatry. 2007;64:958-965.
6. Kendler KS, Neale M, Kessler R, Heath A, Eaves L. A twin study of recent life events and difficulties. Arch Gen Psychiatry. 1993;50:789-796.
7. Plomin R, Lichtenstein P, Pedersen NL, McClearn GE, Nesselroade JR. Genetic influence on life events during the last half of the life span. Psychol Aging. 1990;5:25-30.
8. Kendler KS, Karkowski-Shuman L. Stressful life events and genetic liability to major depression: genetic control of exposure to the environment? Psychol Med. 1997;27:539-547.
9. Dick DM, Viken R, Purcell S, Kaprio J, Pulkkinen L, Rose RJ. Parental monitoring moderates the importance of genetic and environmental influences on adolescent smoking. J Abnorm Psychol. 2007;116:213-218.
10. Koopmans JR, Slutske WS, van Baal GC, Boomsma DI. The influence of religion on alcohol use initiation: evidence for genotype X environment interaction. Behav Genet. 1999;29:445-453.
11. Dick DM, Rose RJ, Viken RJ, Kaprio J, Koskenvuo M. Exploring gene-environment interactions: Socioregional moderation of alcohol use. J Abnorm Psychol. 2001;110:625-632.
12. Boardman JD. State-level moderation of genetic tendencies to smoke. Am J Public Health. 2009;99:480-486.
13. Kendler KS, Neale MC, Kessler RC, Heath AC, Eaves LJ. Major depression and generalized anxiety disorder: Same genes, (partly) different environments? Arch Gen Psychiatry. 1992;49:716-722.
14. Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003;60:929-937.
15. Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry. 1999;56:921-926.
16. Vollebergh WAM, Iedema J, Bijl RV, de Graaf R, Smit F, Ormel J. The structure and stability of common mental disorders - The NEMESIS Study. Arch Gen Psychiatry. 2001;58:597-603.
17. Pagan JL, Rose RJ, Viken RJ, Pulkkinen L, Kaprio J, Dick DM. Genetic and environmental influences on stages of alcohol use across adolescence and into young adulthood. Behavior Genetics. 2006;36:483-497.
18. Kendler KS, Schmitt E, Aggen SH, Prescott CA. Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch Gen Psychiatry. 2008;65:674-682.
19. Pickens RW, Svikis DS, McGue M, Lykken DT, Heston LL, Clayton PJ. Heterogeneity in the inheritance of alcoholism. Arch Gen Psychiatry. 1991;48:19-28.
20. Johnson EO, van den Bree MB, Pickens RW. Subtypes of alcohol-dependent men: a typology based on relative genetic and environmental loading. Alcoholism: Clin Exp Res. 1996;20:1472-1480.
21. Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry. 1996;53:391-399.
22. Bergen SE, Gardner CO, Kendler KS. Age-related changes in heritability of behavioral phenotypes over adolescence and young adulthood: a meta-analysis. Twin Res Hum Genet. 2007;10:423-433.
23. Haworth CM, Wright MJ, Luciano M, et al. The heritability of general cognitive ability increases linearly from childhood to young adulthood. Mol Psychiatry. In press.
24. Kendler KS, Gardner CO, Annas P, Neale MC, Eaves LJ, Lichtenstein P. A longitudinal twin study of fears from middle childhood to early adulthood: evidence for a developmentally dynamic genome. Arch Gen Psychiatry. 2008;65:421-429.
25. Kendler KS, Gardner CO, Lichtenstein P. A developmental twin study of symptoms of anxiety and depression: evidence for genetic innovation and attenuation. Psychol Med. 2008;38:1567-1575.
26. Kendler KS, Gatz M, Gardner C, Pedersen N. A Swedish national twin study of lifetime major depression. Am J Psychiatry. 2006;163:109-114.
27. Prescott CA, Aggen SH, Kendler KS. Sex differences in the sources of genetic liability to alcohol abuse and dependence in a population-based sample of U.S. twins. Alcohol Clin Exp Res. 1999;23:1136-1144.
28. Kendler KS. Gender differences in the genetic epidemiology of major depression. J Gend Specif Med. 1998;1:28-31.
29. Dick DM, Aliev F, Wang JC, et al. Using dimensional models of externalizing psychopathology to aid in gene identification. Arch Gen Psychiatry. 2008;65:310-318.
30. Hettema JM, An SS, Neale MC, et al. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry. 2006;11:752-762.
31. Slutske WS, Heath AC, Dinwiddle SH, et al. Common genetic risk factors for conduct disorder and alcohol dependence. J Abn Psychol 1998;107:363-374.
32. Edenberg HJ, Dick DM, Xuei X, et al. Variations in GABRA2, encoding the a2 subunit of the GABA-A receptor are associated with alcohol dependence and with brain oscillations. Am J Hum Genet. 2004;74:705-714.
33. Wang JC, Hinrichs AL, Stock H, et al. Evidence of common and specific genetic effects: Association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet. 2004;13:1903-1911.
34. Dick DM, Latendresse SJ, Lansford JE, et al. The role of GABRA2 in trajectories of externalizing behavior across development and evidence of moderation by parental monitoring. Arch Gen Psychiatry. 2009;66:649-657.
35. Latendresse SJ, Bates J, Goodnight JA, et al. Differential susceptibility to discrete patterns of adolescent externalizing behavior: examining the interplay between CHRM2 and Peer group deviance. Child Dev. 2009. In press.
36. Dick DM, Bierut L, Hinrichs AL, et al. The role of GABRA2 in risk for conduct disorder and alcohol and drug dependence across developmental stages. Behavior Genetics. 2006;36:577-590.
37. Dick DM, Pagan JL, Viken R, et al. Changing environmental influences on substance use across development. twin research and human genetics 2007;10:315-326.
38. Button TM, Corley RP, Rhee SH, Hewitt JK, Young SE, Stallings MC. Delinquent peer affiliation and conduct problems: a twin study. J Abnorm Psychol. 2007;116:554-564.
39. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516-1517.
40. Riley BP, McGuffin P. Linkage and associated studies of schizophrenia. Am J Med Genet Sem Med Genet. 2000;97:23-44.
41. Sullivan PF. The genetics of schizophrenia. PLoS Med. 2005;2:e212.
42. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry. 1999;56:940-945.
43. Pulver AE, Nestadt G, Goldberg R, et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis. 1994;182:476-478.
44. Karayiorgou M, Morris MA, Morrow B, et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci U S A. 1995;92:7612-7616.
45. Williams HJ, Owen MJ, O'Donovan MC. Is COMT a susceptibility gene for schizophrenia? Schizophr Bull. 2007;33:635-641.
46. Lewis CM, Levinson DF, Wise LH, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet. 2003;73:34-48.
47. Stefansson H, Sigurdsson E, Steinthorsdottir V, et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet. 2002;71:877-892.
48. Stefansson H, Sarginson J, Kong A, et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet. 2003;72:83-87.
49. Corvin AP, Morris DW, McGhee K, et al. Confirmation and refinement of an 'at-risk' haplotype for schizophrenia suggests the EST cluster, Hs.97362, as a potential susceptibility gene at the Neuregulin-1 locus. Mol Psychiatry. 2004;9:208-213.
50. Williams NM, Preece A, Spurlock G, et al. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry. 2003;8:485-487.
51. Yang JZ, Si TM, Ruan Y, et al. Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry. 2003;8:706-709.
52. Bakker SC, Hoogendoorn ML, Selten JP, et al. Neuregulin 1: genetic support for schizophrenia subtypes. Mol Psychiatry. 2004;9:1061-1063.
53. Li T, Stefansson H, Gudfinnsson E, et al. Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Mol Psychiatry. 2004;9:698-704.
54. Tang JX, Chen WY, He G, et al. Polymorphisms within 5' end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol Psychiatry. 2004;9:11-12.
55. Zhao X, Shi Y, Tang J, et al. A case control and family based association study of the neuregulin1 gene and schizophrenia. J Med Genet. 2004;41:31-34. 56.
56. Petryshen TL, Middleton FA, Kirby A, et al. Support for involvement of neuregulin 1 in schizophrenia pathophysiology. Mol Psychiatry. 2005;10:366-374.
57. Fukui N, Muratake T, Kaneko N, Amagane H, Someya T. Supportive evidence for neuregulin 1 as a susceptibility gene for schizophrenia in a Japanese population. Neurosci Lett. 2006;396:117-120.
58. Hall J, Whalley HC, Job DE, et al. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci. 2006;9:1477-1478.
59. Norton N, Moskvina V, Morris DW, et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2006;141:96-101.
60. Thomson PA, Christoforou A, Morris SW, et al. Association of Neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry. 2007;12:94-104.
61. Turunen JA, Peltonen JO, Pietilainen OP, et al. The role of DTNBP1, NRG1, and AKT1 in the genetics of schizophrenia in Finland. Schizophr Res. 2007;91:27-36.
62. Georgieva L, Dimitrova A, Ivanov D, et al. Support for Neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biol Psychiatry. 2008;64:419-427.
63. Hall D, Gogos JA, Karayiorgou M. The contribution of three strong candidate schizophrenia susceptibility genes in demographically distinct populations. Genes Brain Behav. 2004;3:240-248.
64. Iwata N, Suzuki T, Ikeda M, et al. No association with the neuregulin 1 haplotype to Japanese schizophrenia. Mol Psychiatry. 2004;9:126-127.
65. Thiselton DL, Webb BT, Neale BM, et al. No evidence for linkage or association of neuregulin-1 (NRG1) with disease in the Irish study of high-density schizophrenia families (ISHDSF). Mol Psychiatry. 2004;9:777-783.
66. Duan J, Martinez M, Sanders AR, et al. Neuregulin 1 (NRG1) and schizophrenia: analysis of a US family sample and the evidence in the balance. Psychol Med. 2005;35:1599-1610.
67. Ingason A, Soeby K, Timm S, et al. No significant association of the 5' end of neuregulin 1 and schizophrenia in a large Danish sample. Schizophr Res. 2006;83:1-5.
68. Walss-Bass C, Raventos H, Montero AP, et al. Association analyses of the neuregulin 1 gene with schizophrenia and manic psychosis in a Hispanic population. Acta Psychiatr Scand. 2006;113:314-321.
69. Rosa A, Gardner M, Cuesta MJ, et al. Family-based association study of neuregulin-1 gene and psychosis in a Spanish sample. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:954-957.
70. Vilella E, Costas J, Sanjuan J, et al. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res. 2008;42:278-288.
71. Ikeda M, Takahashi N, Saito S, et al. Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample. Schizophr Res. 2008;101:1-8.
72. Munafo MR, Thiselton DL, Clark TG, Flint J. Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry. 2006;11:539-546.
73. Green EK, Raybould R, Macgregor S, et al. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder. Arch Gen Psychiatry. 2005;62:642-648.
74. Thomson PA, Wray NR, Millar JK, et al. Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population. Mol Psychiatry. 2005;10:657-668.
75. Hahn CG, Wang HY, Cho DS, et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med. 2006;12:824-828.
76. Nicodemus KK, Luna A, Vakkalanka R, et al. Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol Psychiatry. 2006;11:1062-1065.
77. Silberberg G, Darvasi A, Pinkas-Kramarski R, Navon R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:142-148.
78. Benzel I, Bansal A, Browning BL, et al. Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav Brain Funct. 2007;3:31.
79. Law AJ, Kleinman JE, Weinberger DR, Weickert CS. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet. 2007;16:129-141.
80. Straub RE, MacLean CJ, O'Neill FA, et al. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: Evidence for genetic heterogeneity. Nature Genetics. 1995;11:287-293.
81. Levinson DF, Wildenauer DB, Schwab SG, et al. Additional support for schizophrenia linkage on chromosomes 6 and 8: A multicenter study. Am J Med Genet Neuropsych Genet. 1996;67:580-594.
82. Straub RE, Jiang Y, MacLean CJ, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of mouse dysbindin, is associated with schizophrenia. Am J Hum Genet. 2002;71:337-348.
83. van den Oord E, Sullivan PF, Chen X, Kendler KS, Riley B. Identification of a high risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high density schizophrenia families. Mol Psychiatry. 2003;8:499-510.
84. Schwab SG, Knapp M, Mondabon S, et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet. 2003;72:185-190.
85. Van Den Bogaert A, Schumacher J, Schulze TG, et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet. 2003;73:1438-1443.
86. Tang JX, Zhou J, Fan JB, Li XW, et al. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol Psychiatry. 2003;8:717-718.
87. Funke B, Finn CT, Plocik AM, et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am J Hum Genet. 2004;75:891-898.
88. Kirov G, Ivanov D, Williams NM, et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in parent-offspring trios from Bulgaria. Biol Psychiatry. 2004;55:971-975.
89. Numakawa T, Yagasaki Y, Ishimoto T, et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet. 2004;13:2699-2708.
90. Williams NM, Preece A, Morris DW, et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch Gen Psychiatry. 2004;61:336-344.
91. Li T, Zhang F, Liu X, et al. Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations. Mol Psychiatry. 2005;10:1037-1044.
92. Tochigi M, Zhang X, Ohashi J, et al. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci Res. 2006;56:154-158.
93. Tosato S, Ruggeri M, Bonetto C, et al. Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:647-659.
94. DeLuca V, Voineskos D, Shinkai T, Wong G, Kennedy JL. Untranslated region haplotype in dysbindin gene: analysis in schizophrenia. J Neural Transm. 2005;112:1263-1267.
95. Holliday EG, Handoko HY, James MR, et al. Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Twin Res Hum Genet. 2006;9:531-539.
96. Joo EJ, Lee KY, Jeong SH, Ahn YM, Koo YJ, Kim YS. The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population. Neurosci Lett. 2006;407:101-106.
97. Liu CM, Liu YL, Fann CS, et al. No association evidence between schizophrenia and dystrobrevin-binding protein 1 (DTNBP1) in Taiwanese families. Schizophr Res. 2007;doi:10.1016/j.schres.2007.02.003.
98. Pedrosa E, Ye K, Nolan KA, et al. Positive association of schizophrenia to JARID2 gene. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:45-51.
99. Wood LS, Pickering EH, Dechairo BM. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol Psychiatry. 2007;61:1195-1199.
100. Bakker SC, Hoogendoorn ML, Hendriks J, Verzijlbergen K, Caron S, Verduijn W, et al. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav. 2007;6:113-119.
101. Datta SR, McQuillin A, Puri V, et al. Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1) locus and schizophrenia. Behav Brain Funct. 2007;3:50.
102. Peters K, Wiltshire S, Henders AK, et al. Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:1159-1166.
103. Sanders AR, Duan J, Levinson DF, et al. No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric genetics. Am J Psychiatry. 2008;165:497-506.
104. Morris DW, McGhee KA, Schwaiger S, et al. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr Res. 2003;60:167-172.
105. Fallin MD, Lasseter VK, Avramopoulos D, et al. Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet. 2005;77:918-936.
106. Breen G, Prata D, Osborne S, et al. Association of the dysbindin gene with bipolar affective disorder. Am J Psychiatry. 2006;163:1636-1638.
107. Joo EJ, Lee KY, Jeong SH, et al. Dysbindin gene variants are associated with bipolar I disorder in a Korean population. Neurosci Lett. 2007;418:272-275.
108. Pae CU, Serretti A, Mandelli L, et al. Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:701-703.
109. Weickert CS, Straub RE, McClintock BW, et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry. 2004;61:544-555.
110. Talbot K, Eidem WL, Tinsley CL, et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest. 2004;113:1353-1363.
111. St Clair D, Blackwood D, Muir W, et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet. 1990;336:13-16.
112. Millar JK, Wilson-Annan JC, Anderson S, et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet. 2000;9:1415-1423.
113. Hennah W, Varilo T, Kestila M, et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet. 2003;12:3151-3159.
114. Hodgkinson CA, Goldman D, Jaeger J, et al. Disrupted in schizophrenia 1 (DISC1): association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet. 2004;75:862-872.
115. Callicott JH, Straub RE, Pezawas L, et al. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A. 2005;102:8627-8632.
116. Cannon TD, Hennah W, van Erp TG, et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired shortand long-term memory. Arch Gen Psychiatry. 2005;62:1205-1213.
117. Liu YL, Fann CS, Liu CM, et al. A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: Association with impairment of sustained attention. Biol Psychiatry. 2006;60:554-562.
118. Zhang F, Sarginson J, Crombie C, Walker N, St CD, Shaw D. Genetic association between schizophrenia and the DISC1 gene in the Scottish population. Am J Med Genet B Neuropsychiatr Genet. 2006;141:155-159.
119. Palo OM, Antila M, Silander K, et al. Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments. Hum Mol Genet. 2007;16:2517-2528.
120. Qu M, Tang F, Yue W, et al. Positive association of the Disrupted-in-Schizophrenia-1 gene (DISC1) with schizophrenia in the Chinese Han population. Am J Med Genet B Neuropsychiatr Genet. 2007;144:266-270.
121. DeRosse P, Hodgkinson CA, Lencz T, et al. Disrupted in schizophrenia 1 genotype and positive symptoms in schizophrenia. Biol Psychiatry. 2007;61:1208-1210.
122. Szeszko PR, Hodgkinson CA, Robinson DG, et al. DISC1 is associated with prefrontal cortical gray matter and positive symptoms in schizophrenia. Biol Psychol. 2007;79:103-110.
123. Sachs NA, Sawa A, Holmes SE, Ross CA, DeLisi LE, Margolis RL. A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol Psychiatry. 2005;10:758-764.
124. Song W, Li W, Feng J, Heston LL, Scaringe WA, Sommer SS. Identification of high risk DISC1 structural variants with a 2% attributable risk for schizophrenia. Biochem Biophys Res Commun. 2008;367:700-706.
125. Hennah W, Thomson P, McQuillin A, et al. DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol Psychiatry. 2008;14:865-873.
126. Perlis RH, Purcell S, Fagerness J, et al. Family-based association study of lithium-related and other candidate genes in bipolar disorder. Arch Gen Psychiatry. 2008;65:53-61.
127. Kockelkorn TT, Arai M, Matsumoto H, et al. Association study of polymorphisms in the 5' upstream region of human DISC1 gene with schizophrenia. Neurosci Lett. 2004;368:41-45.
128. Zhang X, Tochigi M, Ohashi J, et al. Association study of the DISC1/TRAX locus with schizophrenia in a Japanese population. Schizophr Res. 2005;79:175-180.
129. Chen QY, Chen Q, Feng GY, et al. Case-control association study of Disrupted-in-Schizophrenia-1 (DISC1) gene and schizophrenia in the Chinese population. J Psychiatr Res. 2007;41:428-434.
130. Kim HJ, Park HJ, Jung KH, et al. Association study of polymorphisms between DISC1 and schizophrenia in a Korean population. Neurosci Lett. 2008;430:60-63.
131. Chen X, Wang X, Hossain S, et al. Interleukin 3 and schizophrenia: the impact of sex and family history. Mol Psychiatry. 2007;12:273-282.
132. Freedman R, Coon H, Myles-Worsley M, et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A. 1997;94:587-592.
133. Riley BP, Makoff A, Mogudi-Carter M, et al. Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in southern African Bantu families. Am J Med Genet Neuropsychiatric Genet. 2000;96:196-201.
134. Liu CM, Hwu HG, Lin MW, et al. Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families. Am J Med Genet. 2001;105:658-661.
135. Tsuang DW, Skol AD, Faraone SV, et al. Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. Am J Med Genet. 2001;105:662-668.
136. Xu J, Pato MT, Torre CD, et al. Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families. Am J Med Genet. 2001;105:669-674.
137. Gejman PV, Sanders AR, Badner JA, Cao Q, Zhang J. Linkage analysis of schizophrenia to chromosome 15. Am J Med Genet. 2001;105:789-793.
138. Liu H, Heath SC, Sobin C, et al. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci U S A. 2002;99:3717-3722.
139. Gerber DJ, Hall D, Miyakawa T et al. Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit. Proc Natl Acad Sci U S A. 2003;100:8993-8998.
140. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet. 2004;36:131-137.
141. Ikeda M, Iwata N, Suzuki T, et al. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry. 2004;56:698-700.
142. Schwab SG, Hoefgen B, Hanses C, et al. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry. 2005;58:446-450.
143. Bajestan SN, Sabouri AH, Nakamura M, et al. Association of AKT1 haplotype with the risk of schizophrenia in Iranian population. Am J Med Genet B Neuropsychiatr Genet. 2006;141:383-386.
144. Xu MQ, Xing QH, Zheng YL, et al. Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population. J Clin Psychiatry. 2007;68:1358-1367.
145. Thiselton DL, Vladimirov VI, Kuo PH, et al. AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families. Biol Psychiatry. 2008;63:449-457.
146. Ohtsuki T, Inada T, Arinami T. Failure to confirm association between AKT1 haplotype and schizophrenia in a Japanese case-control population. Mol Psychiatry. 2004;9:981-983.
147. Ide M, Ohnishi T, Murayama M, et al. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia. J Neurochem. 2006;99:277-287.
148. Liu YL, Fann CS, Liu CM, et al. Absence of significant associations between four AKT1 SNP markers and schizophrenia in the Taiwanese population. Psychiatr Genet. 2006;16:39-41.
149. Norton N, Williams HJ, Dwyer S, et al. Association analysis of AKT1 and schizophrenia in a UK case control sample. Schizophr Res. 2007;97:271-276.
150. Mah S, Nelson MR, DeLisi LE, et al. Identification of the semaphorin receptor PLXNA2 as a candidate for susceptibility to schizophrenia. Mol Psychiatry. 2006;11:471-478.
151. Fujii T, Iijima Y, Kondo H, et al. Failure to confirm an association between the PLXNA2 gene and schizophrenia in a Japanese population. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:873-877.
152. Takeshita M, Yamada K, Hattori E, et al. Genetic examination of the PLXNA2 gene in Japanese and Chinese people with schizophrenia. Schizophr Res. 2008;99:359-364.
153. Budel S, Shim SO, Feng Z, Zhao H, Hisama F, Strittmatter SM. No association between schizophrenia and polymorphisms of the PlexinA2 gene in Chinese Han Trios. Schizophr Res. 2008;99:365-366.
154. Lencz T, Morgan TV, Athanasiou M, et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry. 2007;12:572-580.
155. Sun S, Wang F, Wei J, et al. Association between interleukin-3 receptor alpha polymorphism and schizophrenia in the Chinese population. Neurosci Lett. 2008;440:35-37.
156. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209-1223.
157. Sullivan PF, Lin D, Tzeng JY, et al. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry. 2008;13:570-584.
158. O'Donovan MC, Craddock N, Norton N, et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet. 2008;40:1053-1055.
159. Riley B, Thiselton D, Maher BS, et al. Replication of association between schizophrenia and ZNF804A in the Irish Case-Control Study of Schizophrenia sample. Mol Psychiatry. 2010;15:29-37.
160. Stefansson H, Ophoff RA, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature. 2009;460:744-747.
161. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-752.
162. Shi J, Levinson DF, Duan J, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 2009;460:753-757.
163. Wassink TH, Piven J, Vieland VJ, et al. Evaluation of the chromosome 2q37.3 gene CENTG2 as an autism susceptibility gene. Am J Med Genet B Neuropsychiatr Genet. 2005;136B:36-44.
164. Allen NC, Bagade S, McQueen MB, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40:827-834.
165. Saxena R, Voight BF, Lyssenko V, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 2007;316:1331-1336.
166. Scott LJ, Mohlke KL, Bonnycastle LL, et al. A genome-wide association study of type 2 diabetes in finns detects multiple susceptibility variants. Science. 2007;316:1341-1345.
167. Sladek R, Rocheleau G, Rung J, et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 2007;445:881-885.
168. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet. 2007;39:770-775.
169. McClellan JM, Susser E, King MC. Schizophrenia: a common disease caused by multiple rare alleles. Br J Psychiatry. 2007;190:194-199.
170. Sebat J, Lakshmi B, Troge J, et al. Large-scale copy number polymorphism in the human genome. Science. 2004;305:525-528.
171. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet. 2004;36:949-951.
172. Tuzun E, Sharp AJ, Bailey JA, et al. Fine-scale structural variation of the human genome. Nat Genet. 2005;37:727-732.
173. Bailey JA, Eichler EE. Primate segmental duplications: crucibles of evolution, diversity and disease. Nat Rev Genet. 2006;7:552-564.
174. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444-454.
175. Gonzalez E, Kulkarni H, Bolivar H, et al. The influence of CCL3L1 genecontaining segmental duplications on HIV-1/AIDS susceptibility. Science. 2005;307:1434-1440.
176. Perry GH, Dominy NJ, Claw KG, et al. Diet and the evolution of human amylase gene copy number variation. Nat Genet. 2007;39:1256-1260.
177. Xu B, Roos JL, Levy S, van Rensburg EJ, Gogos JA, Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet. 2008;40:880-885.
178. Walsh T, McClellan JM, McCarthy SE, et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 2008;320:539-543.
179. Stefansson H, Rujescu D, Cichon S, et al. Large recurrent microdeletions associated with schizophrenia. Nature. 2008;455:232-236.
180. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature. 2008;455: 237-241.
181. Rujescu D, Ingason A, Cichon S, et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet. 2009;18:988-996.
182. McCarthy SE, Makarov V, Kirov G, et al. Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet. 2009;41:1223-1227.
183. Harrison PJ, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet. 2003;361:417-419.
184. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron. 2003;40:881-884.
185. Kendler KS, Parnas J. Philosophical Issues in Psychiatry: Explanation, Phenomenology and Nosology. First ed. Baltimore, MD: Johns Hopkins University Press; 2008.